News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
268,624 Results
Type
Article (9497)
Company Profile (22)
Press Release (259105)
Section
Business (76072)
Career Advice (336)
Deals (16689)
Drug Delivery (36)
Drug Development (40919)
Employer Resources (27)
FDA (7686)
Job Trends (5677)
News (143389)
Policy (15175)
Tag
Academia (702)
Alliances (17710)
Alzheimer's disease (602)
Approvals (7661)
Artificial intelligence (57)
Bankruptcy (170)
Best Places to Work (5135)
Biosimilars (39)
Breast cancer (51)
Cancer (601)
Cardiovascular disease (46)
Career advice (296)
CAR-T (38)
Cell therapy (122)
Clinical research (33578)
Collaboration (161)
COVID-19 (953)
C-suite (39)
Data (747)
Diabetes (69)
Diagnostics (2444)
Drug pricing (47)
Earnings (38251)
Events (35463)
Executive appointments (118)
FDA (7984)
Funding (140)
Gene therapy (84)
GLP-1 (177)
Government (2329)
Healthcare (7386)
Infectious disease (998)
Inflammatory bowel disease (56)
Interviews (50)
IPO (8683)
Job creations (796)
Job search strategy (258)
Layoffs (65)
Legal (2643)
Liver cancer (37)
Lung cancer (90)
Manufacturing (65)
Medical device (5534)
Medtech (5535)
Mergers & acquisitions (8082)
Metabolic disorders (177)
Neuroscience (727)
NextGen Class of 2024 (1804)
Non-profit (1104)
Northern California (766)
Obesity (103)
Opinion (73)
Patents (66)
People (17539)
Phase I (10245)
Phase II (14637)
Phase III (11542)
Pipeline (343)
Postmarket research (987)
Preclinical (3769)
Radiopharmaceuticals (122)
Rare diseases (94)
Real estate (1338)
Regulatory (10804)
Research institute (663)
Resumes & cover letters (42)
Southern California (650)
Startups (854)
United States (6566)
Vaccines (179)
Weight loss (71)
Date
Today (47)
Last 7 days (347)
Last 30 days (2068)
Last 365 days (18771)
2024 (17193)
2023 (21072)
2022 (27932)
2021 (29287)
2020 (26576)
2019 (17918)
2018 (13613)
2017 (13785)
2016 (11723)
2015 (14339)
2014 (9843)
2013 (7270)
2012 (7557)
2011 (8176)
2010 (7566)
Location
Africa (237)
Arizona (38)
Asia (19004)
Australia (4938)
California (1642)
Canada (1015)
China (118)
Colorado (61)
Connecticut (89)
Europe (32049)
Florida (251)
Georgia (51)
Illinois (117)
Indiana (89)
Japan (41)
Maryland (223)
Massachusetts (1276)
Michigan (37)
Minnesota (71)
New Jersey (611)
New York (547)
North Carolina (302)
Northern California (766)
Ohio (49)
Pennsylvania (447)
South America (390)
Southern California (650)
Texas (232)
Washington State (257)
268,624 Results for "teva canada limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
Teva Reports Strong Generics Demand in Q3, Expects Higher 2024 Revenue
Driven by copycat versions of Bristol Myers Squibb’s Revlimid and Novo Nordisk’s Victoza, Teva’s generics business was again a top-performer in the third quarter, with U.S. sales growing 30% and bringing in $1.1 billion in sales.
November 7, 2024
·
2 min read
·
Tristan Manalac
Business
Teva Canada Named by Forbes as No. 1 Canadian Employer in Drugs & Biotechnology Industry
Teva Canada Named by Forbes as No. 1 Canadian Employer in Drugs & Biotechnology Industry.
February 7, 2024
·
4 min read
Legal
Teva to Pay $450M in Settlement With DOJ Over Kickback and Price-Fixing Allegations
The U.S. Department of Justice alleged that Teva violated the Anti-Kickback Statute and the False Claims Act. The payment is in addition to the criminal penalty paid by Teva USA under its deferred prosecution agreement.
October 11, 2024
·
2 min read
·
Tristan Manalac
Business
Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations
Teva Pharmaceutical Industries Ltd. today announced the appointment of Matthew Shields as Executive Vice President of Teva Global Operations (TGO), the Company’s manufacturing and supply division, effective June 3, 2024.
May 15, 2024
·
7 min read
Teva to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva’s President and CEO, will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Tuesday, June 11, 2024.
June 4, 2024
·
2 min read
Pharm Country
Teva Announces Launch of Authorized Generic of Victoza® (liraglutide injection 1.8mg), in the United States
Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the launch of an authorized generic of Victoza®1 (liraglutide injection 1.8mg), in the United States.
June 24, 2024
·
9 min read
Bio NC
Caidya Expands Global Presence with the Establishment of Caidya Canada Limited and New Office in Toronto
Caidya, a leading global, multi-therapeutic clinical research organization, is pleased to announce the establishment of its new legal entity, Caidya Canada Limited, and the opening of its new office in Toronto, Ontario.
April 1, 2024
·
2 min read
Policy
Teva Pays $750M to Resolve Israeli Tax Issues Going Back More Than a Decade
Teva Pharmaceuticals has settled years of tax litigation with the Israel Tax Authority for $750 million, which the company will pay in installments starting in 2024 to 2029.
June 26, 2024
·
2 min read
·
Tristan Manalac
Policy
Teva Loses Inhaler Patent Case Against Amneal, Must Delete or Amend Orange Book Listing
Teva Pharmaceuticals lost its patent row with Amneal Pharmaceuticals on Monday as a New Jersey court ruled that some of Teva’s claims over its inhaler product ProAir HFA were improperly listed on the FDA’s Orange Book.
June 12, 2024
·
2 min read
·
Tristan Manalac
Teva to Present at the 2024 Bank of America Healthcare Conference
Teva Pharmaceutical Industries Ltd. announced that Richard Francis, Teva’s President and CEO, will present at the 2024 Bank of America Healthcare Conference on Tuesday, May 14, 2024.
May 2, 2024
·
2 min read
1 of 26,863
Next
